Why dysphagia in ALS defines prognosis and quality of life
In ALS, dysphagia is not simply 'choking': it is a condition that accelerates deterioration through three specific pathways: aspiration → pneumonia and respiratory infections; reduced intake → weight loss and dehydration; mealtime fatigue and anxiety → social isolation and diminished quality of life. Furthermore, it frequently coexists with sialorrhoea and respiratory compromise, compounding the risk. Contemporary management is not 'puréed diet and done' but a multidisciplinary plan incorporating instrumental assessment, IDDSI-standardised diet modifications, secretion management, proactive nutrition and informed gastrostomy decision-making.
For families: if your relative has ALS and you notice swallowing difficulties, weight loss or increased saliva, this guide explains what is happening and what options are available.
Why does dysphagia develop in ALS?
ALS damages the motor neurones controlling the muscles of the tongue, pharynx and larynx. This results in:
- Lingual and pharyngeal weakness: Reduced bolus propulsion, increased pharyngeal residue after swallowing. Food remains in the pharynx and may fall into the airway.
- Impaired coordination due to fatigue and disease progression: The coordination between breathing and swallowing deteriorates, increasing the risk of laryngeal penetration and aspiration. Fatigue worsens progressively throughout the day.
- Sialorrhoea and ineffective cough: Sialorrhoea in ALS is typically not increased salivary production but rather reduced swallowing frequency and impaired secretion management. Combined with ineffective cough, airway clearance capacity is significantly compromised.
A 2024 review summarises that dysphagia is one of the principal bulbar symptoms in ALS and affects more than two thirds of patients throughout the disease course.
Red flags: what should trigger a swallowing assessment
In ALS, 'not coughing' does not mean 'not aspirating'. Aspiration may be silent, particularly when cough is ineffective.
For families: if you notice any of these signs, do not wait. Request a swallowing assessment from the clinical team. Early detection makes a significant difference.
Instrumental assessment: FEES vs VFSS in ALS
Clinical SLT assessment is essential, but many critical decisions (safe textures, silent aspiration risk, gastrostomy timing) benefit from instrumental evaluation:
- FEES (fibreoptic endoscopic evaluation of swallowing): Performed at the bedside, repeatable, no ionising radiation. Highly valuable for visualising secretions, residue and serial monitoring. In ALS, FEES has been described as a dysphagia severity indicator and a useful tool for longitudinal follow-up.
- VFSS / Videofluoroscopic swallow study: Provides comprehensive dynamic visualisation of swallowing biomechanics using fluoroscopy. Particularly valuable when there are uncertainties regarding optimal compensatory strategies or bolus modifications.
GNeuro clinical rule: FEES for rapid decisions, secretion assessment, frequent reassessment or non-transportable patients. VFSS for comprehensive biomechanical analysis and systematic strategy/volume testing.
Evidence-based management of dysphagia in ALS
- Standardise textures and liquids with IDDSI (with scheduled review): Texture and viscosity modification is a safety tool, but is only effective when consistent (same recipe, same thickness) and reviewable. In ALS, disease progression mandates scheduled reassessments to balance safety and quality of life. Use the IDDSI Framework to ensure all carers prepare identical consistencies.
- Proactive (not reactive) nutrition plan: In ALS, weight loss and inadequate intake are not secondary concerns; nutrition is a core component of the clinical strategy. NICE emphasises that the team must monitor weight and intake, provide dietetic support, and — if swallowing is unsafe — conduct evaluation and discuss alternatives including gastrostomy.
- Secretion and sialorrhoea management: Treating sialorrhoea reduces aspirative load and anxiety. The 2024 review emphasises the dysphagia–sialorrhoea dyad in ALS clinical management. Pharmacological and non-pharmacological options are available.
- Patient and carer education: Care logistics are integral to treatment: positioning during meals, pacing, bolus size, avoiding dual-tasking, recognising red flags, criteria for discontinuing oral intake, medication management (crushing/alternatives) and oral hygiene to reduce bacterial load.
Gastrostomy in ALS: timing and decision-making (PEG vs RIG)
This is the most sensitive decision point yet the one that most effectively reduces avoidable crises when addressed proactively.
- Early discussion (do not wait for crisis): NICE is explicit: the team should discuss gastrostomy at an early stage following diagnosis and review at regular intervals as the disease progresses. Early discussion allows time for informed, unhurried decision-making.
- Expected benefits of gastrostomy: Stabilise weight and hydration when oral intake is insufficient or unsafe. Reduce anxiety associated with eating and choking. Facilitate medication administration. The AAN guideline recommends considering enteral nutrition via PEG in ALS patients with low oral intake to stabilise weight (Level B).
- Timing: why 'too late' increases procedural risk: Delaying gastrostomy increases procedural risk as respiratory function declines and weight loss progresses. PEG is generally preferred when respiratory function is adequate, whilst RIG (radiologically inserted gastrostomy) may be preferred when respiratory function is significantly compromised.
- Principal methods: PEG, RIG, PIGG: PEG (percutaneous endoscopic gastrostomy): preferred when respiratory function is preserved. RIG (radiologically inserted gastrostomy): option when respiratory compromise is present. PIGG: hybrid technique (less widely available). The ProGas study (2015) describes the principal gastrostomy methods in ALS and underscores that timing and method selection have been heavily influenced by clinical consensus.
Important: gastrostomy does not mean stopping oral intake. It is frequently placed while the patient is still eating orally and used for nutritional 'top-up'. The oral/enteral balance is then adjusted as the disease progresses, always through shared decision-making.
ALS dysphagia management algorithm
What NOT to do (or not routinely) in ALS with dysphagia
- Thicken or purée without assessment: may improve safety but worsen hydration and quality of life if maintained indefinitely without review
- Wait for 'crisis' to discuss gastrostomy: NICE mandates early discussion and regular reviews
- Treat swallowing alone without addressing secretions: sialorrhoea and secretion management are integral to the problem
- Fail to monitor weight and intake: in ALS, nutrition is not secondary — it is a therapeutic axis
Evidence Sources
Fuentes
- 2024 review on dysphagia and sialorrhoea in ALS: bulbar symptom frequency and clinical management
- NICE: discuss gastrostomy early following ALS diagnosis, with periodic review
- AAN (Neurology 2009): consider PEG in ALS with low oral intake to stabilise weight (Level B)
- FEES as a dysphagia severity indicator and follow-up tool in ALS (ScienceDirect)
- ProGas study (2015): gastrostomy methods in ALS and timing considerations
- IDDSI Framework: texture and thickness standardisation
- MND Association: PEG vs RIG criteria based on respiratory function
Request a multidisciplinary assessment (SLT + nutrition + respiratory) + safe transition plan (oral → mixed → enteral) tailored to patient preferences at GNeuro.